These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 38064656)

  • 1. Adolescents and Young Adults With Cancer: CNS Tumors.
    Wu J; Heidelberg RE; Gajjar A
    J Clin Oncol; 2024 Feb; 42(6):686-695. PubMed ID: 38064656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain Tumor Imaging in Adolescents and Young Adults: 2021 WHO Updates for Molecular-based Tumor Types.
    Wagner MW; Jabehdar Maralani P; Bennett J; Nobre L; Lim-Fat MJ; Dirks P; Laughlin S; Tabori U; Ramaswamy V; Hawkins C; Ertl-Wagner BB
    Radiology; 2024 Feb; 310(2):e230777. PubMed ID: 38349246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain Tumors in Adolescents and Young Adults: A Review.
    Rousseau J; Bennett J; Lim-Fat MJ
    Semin Neurol; 2023 Dec; 43(6):909-928. PubMed ID: 37949116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment and Outcomes for Central Nervous System Tumors in Australian Adolescents and Young Adults: A Population-Based National Study.
    Harrup R; White VM; Coory M; Walker R; Anazodo A; Skaczkowski G; Bibby H; Osborn M; Phillips MB; Conyers R; Thompson K; Orme LM; Pinkerton R; Nicholls W
    J Adolesc Young Adult Oncol; 2021 Apr; 10(2):202-208. PubMed ID: 32856982
    [No Abstract]   [Full Text] [Related]  

  • 5. Advances in the biology and treatment of pediatric central nervous system tumors.
    Vitanza NA; Cho YJ
    Curr Opin Pediatr; 2016 Feb; 28(1):34-9. PubMed ID: 26709691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The unique immune ecosystems in pediatric brain tumors: integrating single-cell and bulk RNA-sequencing.
    Cao L; Xie W; Ma W; Zhao H; Wang J; Liang Z; Tian S; Wang B; Ma J
    Front Immunol; 2023; 14():1238684. PubMed ID: 38094301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Trial Enrollment Among Adolescent and Young Adults with Primary Central Nervous System Tumors Treated at the Dana-Farber Cancer Institute.
    Sarvode S; Vogelzang JR; Sarvode Mothi S; Warren KE; Reardon DA; Yeo KK
    J Adolesc Young Adult Oncol; 2022 Dec; 11(6):543-549. PubMed ID: 35049364
    [No Abstract]   [Full Text] [Related]  

  • 8. Children's Oncology Group's 2023 blueprint for research: Central nervous system tumors.
    Leary SES; Onar-Thomas A; Fangusaro J; Gottardo NG; Cohen K; Smith A; Huang A; Haas-Kogan D; Fouladi M;
    Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30600. PubMed ID: 37534382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in the molecular classification of pediatric brain tumors: a guide to the galaxy.
    Cacciotti C; Fleming A; Ramaswamy V
    J Pathol; 2020 Jul; 251(3):249-261. PubMed ID: 32391583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of the genomic landscape of common pediatric CNS tumors and how data sharing will continue to shape this landscape in the future.
    Kaneva K; Goldman S
    Mol Biol Rep; 2021 Nov; 48(11):7537-7544. PubMed ID: 34643931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central nervous system.
    Adamson DC; Rasheed BA; McLendon RE; Bigner DD
    Cancer Biomark; 2010; 9(1-6):193-210. PubMed ID: 22112477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric Neuro-Oncology.
    Malbari F
    Neurol Clin; 2021 Aug; 39(3):829-845. PubMed ID: 34215389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploiting Laboratory Insights to Improve Outcomes of Pediatric Central Nervous System Tumors.
    Robinson GW; Witt H; Resnick A
    Am Soc Clin Oncol Educ Book; 2016; 35():e540-6. PubMed ID: 27249765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric CNS tumors: current treatment and future directions.
    Hargrave DR; Zacharoulis S
    Expert Rev Neurother; 2007 Aug; 7(8):1029-42. PubMed ID: 17678498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric brain tumors: the era of molecular diagnostics, targeted and immune-based therapeutics, and a focus on long term neurologic sequelae.
    Plant-Fox AS; O'Halloran K; Goldman S
    Curr Probl Cancer; 2021 Aug; 45(4):100777. PubMed ID: 34303558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Journal of Neuro Oncology: Diagnostic and therapeutic implications of IDH mutations in gliomas following the 2021 World Health Organization classification of CNS tumors.
    Juratli TA; Jungk C; Miller JJ
    J Neurooncol; 2023 May; 162(3):457-459. PubMed ID: 37212938
    [No Abstract]   [Full Text] [Related]  

  • 17. CNS Tumors in Adolescents and Young Adults: The Need for a Holistic Specialized Approach.
    Papageorgiou GI; Razis ED
    JCO Oncol Pract; 2020 Apr; 16(4):155-162. PubMed ID: 32048937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current practice of cancer predisposition testing in pediatric patients with CNS tumors in the United States.
    Roy B; Knapke S; Pillay-Smiley N; Zhang X; Queen K; Sisson R
    Pediatr Blood Cancer; 2024 Jan; 71(1):e30725. PubMed ID: 37859593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct demographic profile and molecular markers of primary CNS tumor in 1873 adolescent and young adult patient population.
    Vadgaonkar R; Epari S; Chinnaswamy G; Krishnatry R; Tonse R; Gupta T; Jalali R
    Childs Nerv Syst; 2018 Aug; 34(8):1489-1495. PubMed ID: 29730791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comorbidity Burden in a Cohort of Adolescent and Young Adult Patients Diagnosed with Central Nervous System Tumors and Sarcomas.
    Lazow MA; Salloum R; Pressey JG
    J Adolesc Young Adult Oncol; 2023 Apr; 12(2):215-223. PubMed ID: 35675692
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.